[New European Medicines Agency approval: Tucatinib in association with trastuzumab and capecitabine for the treatment of HER2-positive metastatic breast cancer previously treated].
作者信息
Bonnemort Justine, Bellesoeur Audrey
机构信息
Centre hospitalo-universitaire de Poitiers, département d'oncologie médicale, 86021 Poitiers, France.
Institut Curie, département d'oncologie médicale, 75005 Paris, France; Institut Curie, département de radio-pharmacologie, 92210 Saint-Cloud, France.
出版信息
Bull Cancer. 2021 Jul-Aug;108(7-8):673-675. doi: 10.1016/j.bulcan.2021.04.004. Epub 2021 Jun 23.
PMID:34172272
Abstract
摘要
Zotero 插件